Alps Advisors Inc. acquired a new position in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 9,970 shares of the company's stock, valued at approximately $361,000. Alps Advisors Inc. owned 0.10% of Semler Scientific at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Interchange Capital Partners LLC acquired a new stake in Semler Scientific in the first quarter worth about $46,502,000. Capital International Investors acquired a new stake in Semler Scientific in the fourth quarter worth about $30,813,000. Susquehanna Advisors Group Inc. acquired a new stake in Semler Scientific in the fourth quarter worth about $26,928,000. Driehaus Capital Management LLC acquired a new stake in Semler Scientific in the fourth quarter worth about $10,122,000. Finally, Thames Capital Management LLC acquired a new stake in Semler Scientific in the fourth quarter worth about $6,465,000. Institutional investors and hedge funds own 49.37% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the stock. Maxim Group upgraded shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price target on the stock in a research report on Wednesday, July 9th. Benchmark assumed coverage on shares of Semler Scientific in a research report on Tuesday, July 8th. They issued a "buy" rating and a $101.00 price target on the stock. Finally, Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
Read Our Latest Report on Semler Scientific
Semler Scientific Trading Down 5.4%
NASDAQ SMLR traded down $2.36 on Friday, hitting $41.24. 622,725 shares of the company were exchanged, compared to its average volume of 579,377. The company's 50 day moving average price is $38.38 and its 200-day moving average price is $41.37. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. The firm has a market capitalization of $564.58 million, a P/E ratio of -15.80 and a beta of 1.39. Semler Scientific Inc. has a twelve month low of $21.77 and a twelve month high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
